Jaime Barberena, MD
Cardiovascular Disease · Topeka, KSNPI 1598764664
Payments from drug & device makers
Across 28 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$166
- Medtronic$129
- Abiomed$123
- Abbott$96
- Boston Scientific$44
- Bard Peripheral Vascular, Inc.$25
- plus $17 from 1 others
What the payments were for
- Food & beverage$600100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiovascular Systems Inc. | 20 | $166 |
| Medtronic | 2 | $129 |
| Abiomed | 2 | $123 |
| Abbott | 1 | $96 |
| Boston Scientific | 1 | $44 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Amgen | 1 | $17 |
How this compares
$600 in reported general payments places this provider in the 15th percentile of 175 cardiovascular disease providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 70 | $63,142 |
| BrilintaTicagrelor | 31 | $20,771 |
| Repatha SureclickEvolocumab | 13 | $8,115 |
| ClopidogrelClopidogrel Bisulfate | 349 | $3,389 |
| Atorvastatin Calcium | 299 | $2,437 |
| Rosuvastatin Calcium | 87 | $1,539 |
| Bisoprolol Fumarate | 45 | $1,516 |
| Metoprolol Succinate | 116 | $1,375 |
| Ezetimibe | 67 | $1,349 |
| Prasugrel Hcl | 41 | $1,259 |
| Carvedilol | 167 | $1,246 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 101 | $1,222 |
| Gabapentin | 18 | $1,180 |
| Pravastatin Sodium | 41 | $649 |
| Losartan Potassium | 87 | $618 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Topeka
- Chen Hoe ChowTopeka$187K
- Raymond DattiloTopeka$13K
- John JoliffTopeka$7K
- Patrick SheehyTopeka$7K
- Bassem ChehabWichita$5.9M
- Wassim ShaheenWichita$1M
- Aziz MaksoudWichita$847K
- Stephen BloomOverland Park$766K
- Vasvi SinghOverland Park$436K
- Lloyd StahlOverland Park$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.